JOHNSON & JOHNSON

The Club is adding to our position in a key holding as its share price drops.

A U.S. appeals court has dismissed the bankruptcy case filed by a Johnson & Johnson spinoff company. Around 40,000 cancer patients have filed suit, alleging the powder was contaminated with asbestos.

The new year has been tough on pharmaceutical stocks, including JNJ. But it should not be read as an indictment on the company's operations.

The Investing Club holds its "Morning Meeting" every weekday at 10:20 a.m. ET.

Big day of earnings for Club holdings as the Dow, S&P 500 and Nasdaq look to open lower after back-to-back gains.

Johnson & Johnson beat earnings expectations in the final quarter of 2022 even as a strong dollar and sinking COVID-19 vaccine sales hurt revenue.

Federal prosecutors say a subsidiary of health care company Johnson & Johnson has agreed to pay nearly $10 million to settle allegations that it violated federal and state law by providing free products to a surgeon.

Earle Dickson invented the Band-Aid in 1921. A cotton buyer for Johnson & Johnson, he was inspired to create the new product to treat's wife household wounds.

FDA Commissioner urges parents not to stockpile children’s flu meds amid shortages

CVS and Walgreens are limiting how many children’s pain relief medications people can buy at once amid the “tripledemic” of respiratory viruses, according to reports.

U.S. drugmaker fights off rivals to acquire maker of treatments for rare autoimmune and inflammatory diseases.

We consider Johnson & Johnson one of our 10 core holdings and will like it even more after the consumer health brand spinoff.

Makers of products like Children's Tylenol say they're trying to keep up with big demand as RSV, flu, and COVID spread. But medical experts note that kids' fevers don't always call for medicine.

The Investing Club holds its "Morning Meeting" every weekday at 10:20 a.m. ET.

"The Dow components all know how to handle a recession," he said.

Johnson & Johnson's (JNJ) $16.6 billion deal to buy heart pump maker Abiomed (ABMD) will bolster its pharmaceutical and medical device business.

These are the stocks posting the largest moves in midday trading Tuesday, Nov. 1.

The Investing Club holds its "Morning Meeting" every weekday at 10:20 a.m. ET.

The stocks making the biggest moves in premarket trading include Abiomed, Uber, SoFi, Pfizer, and more.

Johnson & Johnson is spending about $16.6 billion to buy cardiovascular technology company Abiomed and build up its medical device division.

The fact that Tylenol survived the Tylenol murders is viewed as a shining example of crisis management. But there’s more to the story.

The down days, as painful as they are, seem more muted. The up days show a dearth of supply.

Regulators greenlit to two products from AbbVie (ABBV) and Johnson & Johnson (JNJ). Plus, AbbVie made a small biotech acquisition.

It was a solid quarter for Johnson & Johnson, but the strong dollar is and will remain a headwind for the foreseeable future.

Corporate earnings are holding up despite recession fears, cheering investors. But some analysts urge caution.

With Dow components J&J and Salesforce up strongly, futures tied to the Dow Jones Industrial Average jump more than 600 points.

The stocks posting the largest moves before the bell include Amazon, Hasbro, Nordstrom and more.

Johnson & Johnson topped third-quarter expectations thanks to pharmaceutical sales growth, but a strong dollar made the health care giant tread cautiously again with its outlook.

Asian stock markets are mixed after Wall Street rose on strong corporate profit reports.

Johnson & Johnson, Procter & Gamble and Danaher are the Club stocks set to report. Currency headwinds and inflation will be in focus.

Companies can dodge legal consequences using a bankruptcy process, but critics ask if this just relieves them of accountability.

In anticipation of the early October rally fizzling out in the immediate-term, we raised extra cash earlier in the week.

How the Chicago Tribune reported on the unsolved 1982 Tylenol murders, from interviewing 150 people to reviewing tens of thousands of pages of records.

As the 40th anniversary of the 1982 Tylenol murders approaches, investigators are working with prosecutors on a now-or-maybe-never effort to hold a longtime suspect responsible for the poisonings that killed seven people in the Chicago area, the Tribune has learned.

The Investing Club holds its "Morning Meeting" every weekday at 10:20 a.m. ET.

Drop off unused or expired medications for safe disposal at this upcoming event.

The company has spent billions on cases about one of its most popular products. As its executives try a brazen new legal strategy to stop the litigation, corporate America takes note.

The company has spent billions on cases about one of its most popular products. As its executives try a brazen new legal strategy to stop the litigation, corporate America takes note.

The sudden departure of the company’s problem-solving boss is a blow. But he’s put the consumer giant on a promising path.

The sudden departure of the company’s problem-solving boss is a blow. But he’s put the consumer giant on a promising path.

We still see plenty of opportunities to shuffle our positions and put money to work.

While mindful of a liability risk, we continue to believe this company's exposure will be minimal, if anything.

J&J faced thousands of lawsuits alleging its talcum powder caused users to develop ovarian cancer.

The move comes after thousands of lawsuits from women claiming use of the product gave them ovarian cancer.

Johnson & Johnson is pulling baby powder containing talc worldwide next year after it did the same in the U.S. and Canada amid thousands of lawsuits claiming it had caused cancer.

Thousands of lawsuits claiming that Johnson & Johnson's talc-based powder products contain carcinogens have been filed against the company.

Here's our estimate of what Johnson & Johnson's potential exposure to this litigation could be in a worst-case scenario.

Lilly is expected to report revenue of $6.85 billion and deliver earnings of $1.70 per share.

The companies are also in two sectors that we think are right for this rough market: oil and health care.

Stock futures slumped Tuesday as the Street awaits more quarterly earnings reports.

It was a solid quarter for Johnson & Johnson as its high-quality Pharma franchise continues to march towards its 2025 goal of $60 billion in revenues.

Johnson & Johnson rode growing sales of the cancer treatment Darzalex and other key drugs to a better-than-expected second quarter, but foreign exchange rates again cut into the health care giant’s 2022 forecast.

The clinics “are part of a continued effort by the Ann Arbor YMCA to support Washtenaw and Southern Livingston Counties through the Covid-19 pandemic,” YMCA officials said in a release.

With this stock around our overall cost basis, we want to take the opportunity to get some cash to work and increase our exposure.

Reckitt would be a logical buyer for GSK’s consumer health spinoff Haleon. But the consumer goods giant should be in no rush.

The maker of Pop-Tarts and Pringles is following other corporate giants and splitting up its businesses.

We are making one more small buy today as we still think the market's extreme oversold condition justifies slowly putting money to work.

We continue to find the energy complex attractive due to supply and demand dynamics and the resilience of oil and natural gas pricing.

The Club still thinks a broad-based selloff like Monday is creating a long-term opportunity in stocks with little to do with the concerns of the moment.

Our trading restrictions prevent us from adding to our Johnson & Johnson position today, but we would buy 50 shares this afternoon if we could.

Free COVID-19 vaccinations will be available at three vaccine clinics at Ann Arbor YMCA’s downtown location, 400 W. Washington St., this week.

Johnson & Johnson is suspending sales forecasts for its COVID-19 vaccine only a few months after saying the shot could bring in as much as $3.5 billion this year.

West Virginia will receive $99 million in a settlement finalized with Johnson & Johnson’s subsidiary Janssen Pharmaceuticals Inc. The state filed a lawsuit accusing the drugmaker of contributing to the opioid crisis in the state that's led the nation in overdose deaths.

A California appeals court has upheld a lower court ruling that Johnson & Johnson must pay $302 million in penalties to the state for deceptively marketing pelvic mesh implants for women.

A trial on whether pharmacy chain Walgreens bears responsibility for the opioid crisis started Monday in Florida on the heels of opening statements last week in another opioid trial in West Virginia.

Lawyers for the state of West Virginia are concluding the first week of a trial against three major opioid makers.

Three upcoming vaccine clinics at the Ann Arbor YMCA are free and open to the public.

Drugmaker Johnson & Johnson and three major distributors have finalized a nationwide settlement over their role in the opioid addiction crisis.

Money that will flow to Native American tribes as part of an opioid drug settlement with a major manufacturer and three distributors won't come quickly.

Native American tribes have reached opioid settlements worth over a half-billion dollars with drugmaker Johnson & Johnson and three distributors.

The Czech Republic has recorded a significant decline in people dying of COVID-19 despite facing a record number of infected in one month.

Denmark is scraping most pandemic restrictions as the country no longer considers COVID-19 to be “a socially critical disease.”.

Growing prescription drug and medical device sales nudged Johnson & Johnson past fourth-quarter earnings expectations, and the health care giant’s COVID-19 vaccine gained momentum as well.

The clinic will be held in Ballroom A of the EMU Student Center between 10 a.m. to 4 p.m.

Cahoots will be offering a walk-in COVID vaccine clinic on Thursday.

Oregon is on the verge of signing onto a $26 billion settlement with the three largest distributors of opioids and drugmaker Johnson & Johnson after being one of the latest holdout states to join.

U.S. health officials say most Americans should get the Pfizer or Moderna vaccines instead of the Johnson & Johnson shot.

The European Union drugs regulator says people 18 and older can receive a booster shot for the Johnson & Johnson COVID-19 vaccine at least two months after their initial shot of the one-dose vaccine.

U-M officials issue guidance to school community ahead of holiday travel.

The Supreme Court has turned away a request by Johnson & Johnson to halt a Mississippi lawsuit over its talcum powder products.

Since the coronavirus pandemic began, Dr. Frank McGeorge has been keeping viewers up-to-date and informed on all fronts.

Washington Attorney General Bob Ferguson has taken the state’s case against the nation’s three biggest drug distributors to trial.

Johnson & Johnson is splitting into two companies, separating the division that sells Band-Aids and Listerine from its medical device and prescription drug business.

The Czech government is requiring children to get tested for COVID-19 as part of efforts to curtail a recent steep rise in cases.

The Oklahoma Supreme Court has overturned a $465 million opioid ruling against drugmaker Johnson & Johnson, finding that a lower court wrongly interpreted the state’s public nuisance law.

The NBA has told its players, coaches and referees that they should receive booster shots against the coronavirus, with particular urgency for those who received the single-dose Johnson & Johnson vaccine.

The federal government has canceled a multimillion dollar deal with Emergent BioSolutions, a Maryland- based vaccine manufacturer with facilities in Baltimore that were found to have produced millions of contaminated vaccine doses this spring.

Here we are tracking Michigan’s COVID-19 vaccine coverage.

Top drug manufacturers have won a round in a California lawsuit that blamed them for the opioid crisis and sought billions of dollars to cover the costs of dealing with it.

A California judge has ruled for top drug manufacturers as local governments seek billions of dollars to cover their costs from the nation’s opioid epidemic.

The Food and Drug Administration is enforcing new warnings on breast implants.

The boosters will be available at October drive-through clinics and ongoing walk-in clinics by the Washtenaw County Health Department.

Michiganders who are eligible to receive a COVID-19 vaccine booster dose are urged to do so now.

While vaccines have been overwhelmingly successful at protecting people from contracting the virus, in rare cases, there have been documented illnesses and even deaths.

Michiganders who are eligible to receive a COVID-19 vaccine booster dose from Johnson & Johnson or Moderna are urged to do so now.

Federal health officials say millions more Americans can get a COVID-19 booster and choose a different vaccine for that next shot.

Asian stock markets are higher after Wall Street rose for a fifth day on strong corporate earnings.

Federal regulators are expected to authorize the mixing and matching of COVID-19 booster shots this week.

The Food and Drug Administration is expected to announce this week people will be able to receive a COVID-19 vaccine booster shot with a vaccine from a different manufacturer than their original doses, according to reports in the New York Times, Washington Post and Wall Street Journal.

Sales of the cancer treatment Darzalex helped Johnson & Johnson deliver better-than-expected third quarter earnings, while COVID-19 fueled vaccine revenue and had more customers reaching for Tylenol.